We show that #wellbeing (🥰🤣) is a whole brain process (🧠), with individual differences supported by separable sets of co-active embodied self- (🩷), narrative self- (🗣️), and visual-attention- (👁️) related brain networks: biorxiv.org/content/10.110…

New pre-print🚨with the amazing Daniel Yon @cdfrith We put a Bayesian spin on the classic comparator model of sense of agency; showing how simple gain control mechanisms can account for conterintuitive effects of priors on perception👇

We are now the Centre for Evidence Based Drug Policy! Read the announcement on our homepage: drugpolicycentre.org

If you want evidence based policies empowering and listening to your experts is a good place to start no?

As a hopefully welcome interruption from the riotous IIT discourse on your timeline; my FIRST preprint is out now! Let’s take a minute to think about how the brain does time : biorxiv.org/content/10.110… 🧵 1/14

Friday sees the OFFICIAL LAUNCH of PsyCare’s first ever crowdfunding campaign! 🎊 But this is fundraising with a difference… 👇🏽 (1/n)

15 new synthetic opioids made Class A drugs "as the Govt continues to act to prevent drug deaths" Given the history of other class A's, it's delusional to imagine more prohibitions can meaningfully address the drug death crisis 1/ gov.uk/government/new…

From @charlotte2153: ‘The government is blocking me from getting the treatment I need’ politics.co.uk/mp-comment/202…

Back of the envelope maths suggests that there’s 1 drug related death every 2 hours in the UK. This must change.

Decriminalization is a harm reduction measure, and therefore must be implemented along side other complementary measures to support PWUD. No measure on its own is effective enough

ONS data debunks the notion of cocaine as a rich person's drug. Roughly 2% across income brackets (from <£10,400 to >£52,000) use it, with highest prevalence in the lowest and highest brackets.

BREAKING: ACMD barriers to research part 2 report released. After years of our advocacy, HMG set to address research barriers for Schedule 1 drugs. Recommendations though are limited in scope and short of a significant advance, notably patient access 1/n gov.uk/government/pub…

🚨 New Report Alert! 🚨 Read our analysis on "Naloxone: Legal Challenges and Life-Saving Opportunities" in the battle against opioid deaths. Get it here: drugpolicycentre.org/s/Naloxone-Leg… #Naloxone

The ACMD has released updated workstreams for 2024. We are excited to see that they have self-commissioned a workstream on improving the tracking of ACMD recommendations. It's great to see recommendation 5 from our report "Empowering the ACMD" implemented. static1.squarespace.com/static/5bbb292…

🔔 New Publication Alert 🔔 “Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater” now available in Science of the Total Environment from Richard Bade and collaborators. Check it out ⬇️ 🔗: doi.org/10.1016/j.scit…

The Prescription Medicines Code of Practice Authority's decision on Ethypharm naloxone posters is truly tragic. In the middle of a public health crisis, we need all the tools and info possible to prevent more deaths. Removing public images for overdose awareness is harmful for everyone. pmcpa.org.uk/cases/complete…

iHOST study launch @ St James! Before: inpatient not on community OST, or script not confirmed: dihydrocodiene only. Now: 20mgs methadone PRN, full dose when confirmed. Together, improving care for PWUD. Just a start. Thank you team & Leeds Teaching Hospitals.

It was great to visit the fantastic The Health Shop with Magdalena Harris as part of the SIPP: Safe Inhalation Pipe Provision project today and hear what people thought of the intervention. Paraphernalia laws are non-sensical at the moment and require change!

Thrilled to have started my PhD in Mental Health Science this week at @UCL, supported by Wellcome. Excited for the journey ahead and grateful to be part of such an innovative and supportive program!